Literature DB >> 23559267

Combining antithrombotic and fibrinolytic agents: can it be done?

Pooja Khatri1, Marie-Luise Mono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23559267      PMCID： PMC3840505          DOI： 10.1161/STROKEAHA.111.000090

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  19 in total

1.  Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.

Authors:  Sanne M Zinkstok; Yvo B Roos
Journal:  Lancet       Date:  2012-06-28       Impact factor: 79.321

2.  Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).

Authors:  V Larrue; R von Kummer R; A Müller; E Bluhmki
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

3.  Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).

Authors:  Abdallah G Rebeiz; Per Johanson; Cindy L Green; Suzanne W Crater; Matthew T Roe; Anatoly Langer; Robert P Giugliano; A Michael Lincoff; L Kristin Newby; Robert A Harrington; Eric J Topol; Robert M Califf; Galen S Wagner; Mitchell W Krucoff
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

4.  A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.

Authors:  I K Jang; D F Brown; R P Giugliano; H V Anderson; D Losordo; J C Nicolau; O P Dutra; O Bazzino; V M Viamonte; R Norbady; A S Liprandi; T J Massey; R Dinsmore; R P Schwarz
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

5.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

6.  Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.

Authors:  Maher Saqqur; Carlos A Molina; Abdul Salam; Muzaffar Siddiqui; Marc Ribo; Ken Uchino; Sergio Calleja; Zsolt Garami; Khaurshid Khan; Naveed Akhtar; Finton O'Rourke; Ashfaq Shuaib; Andrew M Demchuk; Andrei V Alexandrov
Journal:  Stroke       Date:  2006-11-30       Impact factor: 7.914

7.  Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.

Authors:  Marta Rubiera; José Alvarez-Sabín; Marc Ribo; Joan Montaner; Esteban Santamarina; Juan F Arenillas; Rafael Huertas; Pilar Delgado; Francisco Purroy; Carlos A Molina
Journal:  Stroke       Date:  2005-06-09       Impact factor: 7.914

8.  Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE).

Authors:  Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Gottfried Schlaug; Roland Bammer; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2008-06-19       Impact factor: 7.914

9.  Ultrasound-enhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial.

Authors:  Andrei V Alexandrov; Andrew M Demchuk; W Scott Burgin; David J Robinson; James C Grotta
Journal:  J Neuroimaging       Date:  2004-04       Impact factor: 2.486

10.  Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.

Authors:  Michael P Marks; Jean-Marc Olivot; Stephanie Kemp; Maarten G Lansberg; Roland Bammer; Lawrence R Wechsler; Gregory W Albers; Vincent Thijs
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105
View more
  1 in total

Review 1.  Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update.

Authors:  Laurent Derex; Chloé Paris; Norbert Nighoghossian
Journal:  J Am Heart Assoc       Date:  2018-01-13       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.